AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$15.72
+3.22% today
Updated 2026-05-11
Market cap
$2.02B
P/E ratio
7.28
P/S ratio
6.78x
EPS (TTM)
$2.16
Dividend yield
—
52W range
$7 – $17
Volume
1.2M
Aurinia Pharmaceuticals Inc (AUPH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $54.35M | $30.64M | $42.67M | $26.66M | $9.55M | $10.28M | $14.32M | $4.16M | $23.14M | $52.38M | $33.57M | $57.00M | $189.85M | $145.86M | $324.30M | $463.66M | $543.37M | $470.86M | $548.06M | $550.64M |
| Cash & equivalents | $16.71M | $13.36M | $32.34M | $21.12M | $4.58M | $6.35M | $5.92M | $184956.00 | $1.82M | $22.71M | $5.76M | $39.65M | $165.63M | $117.97M | $306.02M | $272.35M | $231.90M | $94.17M | $48.88M | $83.43M |
| Current assets | $46.85M | $23.63M | $35.32M | $21.75M | $5.40M | $6.58M | $8.32M | $444297.00 | $2.09M | $33.55M | $16.53M | $41.42M | $175.25M | $132.85M | $315.14M | $419.43M | $513.32M | $442.54M | $424.80M | $446.60M |
| Total liabilities | $11.99M | $10.47M | $14.25M | $18.79M | $4.74M | $3.93M | $7.91M | $6.28M | $9.84M | $7.27M | $13.60M | $21.05M | $24.10M | $33.29M | $25.70M | $55.91M | $64.28M | $65.42M | $170.11M | $173.17M |
| Current liabilities | $9.55M | $6.93M | $10.74M | $9.13M | $3.25M | $1.34M | $2.13M | $3.67M | $6.04M | $2.84M | $3.62M | $7.93M | $8.15M | $7.26M | $11.29M | $32.00M | $40.65M | $46.11M | $77.19M | $97.76M |
| Long-term debt | $2.33M | $612402.00 | $81268.00 | $8.13M | $0.00 | $0.00 | $35304.00 | $0.00 | $0.00 | $11.23M | $5.50M | $9.14M | $11.79M | — | — | — | — | — | — | — |
| Shareholder equity | $42.36M | $20.17M | $28.41M | $7.87M | $4.81M | $6.35M | $6.41M | $-2.12M | $13.30M | $45.11M | $19.96M | $35.95M | $165.74M | $112.58M | $298.60M | $407.75M | $479.09M | $405.44M | $377.95M | $377.48M |
| Retained earnings | $-96.91M | $-119.42M | $-174.38M | $-157.78M | $-190.98M | $-203.82M | $-202.03M | $-217.08M | $-205.37M | $-236.37M | $-257.75M | $-281.05M | $-351.84M | $-415.96M | $-472.48M | $-575.16M | $-756.12M | $-864.30M | $-942.32M | $-936.57M |
| Accounts receivable | $384880.00 | $397220.00 | $488740.00 | $406737.00 | $495654.00 | $113981.00 | $262214.00 | $182785.00 | $106000.00 | $92000.00 | $47000.00 | $86000.00 | $109000.00 | $217000.00 | $368000.00 | $51000.00 | $15.41M | $13.48M | $24.09M | $36.54M |
| Inventory | $268641.00 | $256520.00 | $2.01M | $119967.00 | $1.00 | $1.00 | $194906.00 | $1.00 | $1.00 | — | — | $1.00 | $-109000.00 | — | — | $13.93M | $19.33M | $24.75M | $39.70M | $39.23M |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — | — | — | — |